IPO registrations (S-1, F-1) · Registrants
Asep Medical Holdings Inc.
- SEC CIK
- 1969766 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2024-05-29, last 2024-10-04; 1 initial registration, 2 amendments
- Outcome
- No final prospectus, effectiveness notice or withdrawal within two years of the registration
- Industry (SIC)
- In Vitro & In Vivo Diagnostic Substances 2835
- Incorporated in
- A1
- Business address
- 420-730 VIEW STREET, Victoria, A1 V8W 3Y7
- Ticker
- SEPSF (OTC)
- EDGAR entity type
- other
Offering terms
- Listing
- Nasdaq under the symbol SEPS
- Lead underwriters
- of Contents
- Syndicate
- Aegis Capital
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 3
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2024-05-29 | F-1 | F-1 (foreign registration) | Asep Medical Holdings Inc. | 0001493152-24-021827 ↗ |
| 2024-08-09 | F-1/A | F-1/A (amendment) | Asep Medical Holdings Inc. | 0001493152-24-031003 ↗ |
| 2024-10-04 | F-1/A | F-1/A (amendment) | Asep Medical Holdings Inc. | 0001493152-24-039534 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-04 | F-1/A | registration statement | - | - | Nasdaq SEPS | 2 | primary document; cover names 2 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry In Vitro & In Vivo Diagnostic Substances, A1 first:
- Anbio Biotechnology 2M
- DNA Testing Centers Corp A6
- NYMOX PHARMACEUTICAL CORP A8
- MABCURE INC. B9
- ANSYS DIAGNOSTICS INC CA
- Monogram Biosciences, Inc. CA
- ARGONAUT TECHNOLOGIES INC CA
- GENENCOR INTERNATIONAL INC CA
- Intuity Medical, Inc. CA
- Global Wholehealth Partners Corp CA
In other datasets, the same topic (Health) in A1:
- Form D issuer: 1219014 B.C. Ltd. (Form D private offerings)
Interests: In Vitro & In Vivo Diagnostic Substances · Health